Search
UCSF and I-SPY 2 Breast Cancer Researchers Develop Newly Redefined Breast Cancer Response Subtypes
Research scientists and statisticians from UC San Francisco have developed improved biomarker classifications as part of their research results in the I-SPY 2 trial for high-risk breast cancer patients.Navigating the Maze of Breast Cancer Guidelines: Efficient Paths to Personalized Screening
To help PCPs address patients’ breast cancer screening concerns, surgeon Shoko Emily Abe, MD, FACS, breaks down the multitude of screening directives and modalities, with a focus on the needs of those at average risk and those with dense breast tissue.Better Cancer Care: Pearls From the Best Studies of 2022
Focusing on blood, breast and lung cancers, our specialists deliver exciting findings from the latest phase III trials.Cutting-Edge Approaches to Prostate and Breast Cancers: Reach the Right Decision for Each Patient
In this grand rounds presentation, you’ll learn the best risk assessment tools for prostate cancer patients, the latest surgical techniques, such as fluorescence imaging and high-intensity focused ultrasound, and tests that allow for matching patients with appropriate options.Abortion Ban May Increase Risk of Death for Pregnant Women with Cancer
The repercussions of overturning Roe v. Wade – and the failure of the Supreme Court to provide any guidance on exceptions related to the life and health of the mother – are potentially catastrophic for a subset of women who face a life-threating diagnosis of pregnancy associated cancers (PAC).UCSF Deploys Innovative Data System to Integrate Research and Care
UC San Francisco (UCSF), in collaboration with the Quantum Leap Healthcare Collaborative (QLHC) and the U.S. Food and Drug Administration (FDA) has developed the OneSource system to seamlessly integrate clinical care and research data.Current Menopause Care: Understanding and Explaining a Patient’s Options
Gynecologist Mindy Goldman, MD, offers keys to individualizing care in menopause and beyond by looking at factors ranging from family history to having undergone hysterectomy.Breast Cancer Treatment Strategies: Experts Break Down the Latest
Reporting from the renowned San Antonio Breast Cancer Symposium, UCSF specialists present new research findings relevant to the complicated decisions made daily in designing treatment plans for individual patients.International Breast Cancer Conference Features UCSF Health Experts
Breast cancer experts from UCSF Health will present new research and clinical findings at the annual San Antonio Breast Cancer Symposium, the world’s largest and most prestigious breast cancer conference. This year’s meeting will be held Dec. 7-10.Javid Moslehi, MD, Named Chief of the New UCSF Cardio-Oncology & Immunology Program
Javid Moslehi, MD, has been named section chief of the new Cardio-Oncology & Immunology Program at UC San Francisco, which brings together cardiologists, oncologists, immunologists and researchers to promote the cardiovascular health of patients during cancer treatment and survivorship.How Technology, Human Values and New Scrutiny of Old Methods Are Improving Cancer Outcomes
Three surgical oncologists offer exciting news on hepatobiliary, thyroid and breast cancers. First up is a look at benefits of minimally invasive robotic surgery for rectal cancers; regional therapy for metastatic GI cancer; 3D virtual surgical planning; and biomarkers for pancreatic cysts.Breast Cancer Imaging: How to Optimize Screening for High-Risk Patients
All women should get regular mammograms, but what about those at elevated risk? Radiologist Kimberly Ray, MD, presents this quick update to ensure timely supplemental screening practices and appropriate imaging decisions.Screening Guidelines for Common Cancers: A Lifesaving Update
In just 35 minutes, hematologist-oncologist Akshiv Malhotra, MD, presents the current recommendations on cervical, breast, colon and lung cancers, breaking down the test options for each and when to start tests based on a patient’s risk.A Better Understanding of Breast Cancer Risk: How to Find the Best Options for Individual Patients
Doctors must weigh numerous factors as they seek to identify and manage patients at high breast cancer risk.Breast Changes: Managing Lumps, Pain, Discharge and Other Common Concerns
Breast anatomy is complex, and everything from aging to implants can make exams tricky. Breast surgeon Shoko Emily Abe, MD, FACS, offers help with working up common issues that are often benign yet may require treatment or follow-up.Breast Oncology
Expert care and transformative research working together to improve both survival and quality of lifeMammography 101
Bonnie Joe, MD explains the differences between screening and diagnostic mammography, shows evidence for screening, answers common questions about radiation risk and false positives and discusses digital breast tomosynthesis, also known as 3D mammography.Breast MRI and Advanced Breast Intervention
Bonnie Joe, MD, PhD, discusses how breast MRI is performed, common indications for breast MRI and advanced methods for biopsy and pre-surgical localization of tumors.Screening for Breast Cancer in an Era of Breast Density Legislation
Get an in-depth look at evidence for mammography as a screening tool to reduce mortality via early detection of breast cancer. Also: the value of breast density legislation, density assessments and supplemental screening options like MRI and ultrasound.Cancer Immunotherapy: Promise and Pitfalls
Oncologist David Oh speaks at the October 2017 Bay Area Breast Cancer Forum about key developments in immunotherapy like immune checkpoint inhibitors and T-cell therapies, plus its use in experimental approaches to breast cancer treatment.The Human Microbiome and Breast Cancer
Immunologist Michael Campbell and breast cancer surgeon Laura Esserman speak at the April 2017 Bay Area Breast Cancer Forum about the human biome, how it’s being studied and how it relates to breast cancer prevention and treatment.Updates from the American Society of Clinical Oncology (ASCO) 2017
A June 2017 Bay Area Breast Cancer Forum discussion of updates from the ASCO annual meeting, covering PARP inhibitors, germline BRCA mutations, HER2-positive cancer, patient-reported outcomes, immunotherapy and more. Moderator: Dr. Hope Rugo